Leonard A. Trugman is out as CEO, president, and chair of the board at Del Global Technologies. Financial troubles led to the firing last month of the president and CFO of its Medical Systems Group (SCAN 2/14/01). Trugman “agreed to
Leonard A. Trugman is out as CEO, president, and chair of the board at Del Global Technologies. Financial troubles led to the firing last month of the president and CFO of its Medical Systems Group (SCAN 2/14/01). Trugman “agreed to resign” his position as an officer and director, according to the company, “to pursue other opportunities.” Meanwhile the company’s board elected Samuel E. Park as acting president and CEO, Thomas V. Gilboy as CFO, and Carole Murphy as corporate controller. Roger Winston was elected chair of the board. (George Solomon also resigned from the board, although his leaving is “unrelated to the foregoing,” according to the company.)
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.